MNPR Monopar Therapeutics
Healthcare · Pharmaceutical Preparations · Market cap: $483.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $49.7K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $99.9K | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $25.2K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $1.2M |
| 2025-Q3 | $0 | $36.7M |
| 2025-Q4 | $104.9K | $343.9K |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $3.4M |
| 2026-Q4 | $0 | $1.2M |
Bought$279.7K14 buy days
Sold$42.8M14 sell days
Net insider flow-$42.5Mnet selling · 5 years
Latest trade2026-11-04Tsuchimoto Kim R
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | Sell | Tsuchimoto Kim R | Director | 2,891 | $71.26 | $206.0K | 3 |
| 2026-11-02 | Sell | Anderson Raymond | Director | 3,142 | $68.35 | $214.7K | 4 |
| 2026-11-02 | Sell | Tsuchimoto Kim R | Director | 1,199 | $70.10 | $84.0K | 1 |
| 2026-10-01 | Sell | STARR CHRISTOPHER M | Director | 8,400 | $78.50 | $659.4K | 3 |
| 2026-09-24 | Sell | Robinson Chandler | CEO | 29,056 | $88.00 | $2.6M | 4 |
| 2026-08-26 | Sell | Tsuchimoto Kim R | Director | 4,090 | $111.39 | $455.6K | 6 |
| 2026-08-26 | Sell | RIOUX PATRICE | Other | 1 | $111.26 | $111 | 1 |
| 2026-08-25 | Sell | Anderson Raymond | Director | 3,788 | $111.65 | $422.9K | 4 |
| 2025-12-26 | Buy | Vu Quan Anh | CFO | 1,500 | $69.95 | $104.9K | 1 |
| 2025-12-18 | Sell | KLAUSNER ARTHUR J | Director | 5,121 | $67.15 | $343.9K | 2 |
| 2025-09-24 | Sell | Tactic Pharma LLC | CEO | 550,229 | $63.61 | $35.0M | 1 |
| 2025-07-14 | Sell | STARR CHRISTOPHER M | Director | 16,800 | $40.00 | $672.0K | 1 |
| 2025-07-14 | Sell | Robinson Chandler | CEO | 16,800 | $40.00 | $672.0K | 1 |
| 2025-07-14 | Sell | Tsuchimoto Kim R | Director | 8,904 | $40.00 | $356.2K | 1 |
| 2025-04-02 | Sell | Tactic Pharma LLC | CEO | 33,334 | $35.00 | $1.2M | 1 |
| 2024-10-28 | Buy | Radhakrishnan Karthik | CFO | 1,550 | $16.25 | $25.2K | 1 |
| 2024-06-20 | Buy | Cittadine Andrew | COO | 20,508 | $0.74 | $15.2K | 1 |
| 2024-06-18 | Buy | Cittadine Andrew | COO | 12,000 | $0.86 | $10.3K | 1 |
| 2024-06-17 | Buy | Cittadine Andrew | COO | 12,000 | $0.90 | $10.8K | 1 |
| 2024-06-14 | Buy | Cittadine Andrew | COO | 12,000 | $0.93 | $11.2K | 1 |
| 2024-06-13 | Buy | Cittadine Andrew | COO | 12,000 | $0.91 | $10.9K | 1 |
| 2024-06-04 | Buy | Cittadine Andrew | COO | 12,000 | $0.78 | $9.4K | 1 |
| 2024-06-03 | Buy | Cittadine Andrew | COO | 12,000 | $0.76 | $9.1K | 1 |
| 2024-05-31 | Buy | Cittadine Andrew | COO | 12,000 | $0.64 | $7.7K | 1 |
| 2024-05-30 | Buy | Cittadine Andrew | COO | 12,000 | $0.64 | $7.7K | 1 |
| 2024-05-29 | Buy | Cittadine Andrew | COO | 12,000 | $0.64 | $7.7K | 1 |
| 2022-11-15 | Buy | Cittadine Andrew | COO | 10,000 | $3.15 | $31.5K | 1 |
| 2022-11-14 | Buy | Cittadine Andrew | COO | 6,053 | $3.00 | $18.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Robinson Chandler | CEO | $0 | $39.4M | 2026-09-24 |
| STARR CHRISTOPHER M | Director | $0 | $1.3M | 2026-10-01 |
| Tsuchimoto Kim R | Director | $0 | $1.1M | 2026-11-04 |
| Anderson Raymond | Director | $0 | $637.7K | 2026-11-02 |
| KLAUSNER ARTHUR J | Director | $0 | $343.9K | 2025-12-18 |
| Cittadine Andrew | COO | $149.6K | $0 | 2024-06-20 |
| Vu Quan Anh | CFO | $104.9K | $0 | 2025-12-26 |
| Radhakrishnan Karthik | CFO | $25.2K | $0 | 2024-10-28 |
| RIOUX PATRICE | Other | $0 | $111 | 2026-08-26 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2019-12-18 | 4 | $6.0M | 54 | -38.5% (-36.3% raw) | -48.6% (-71.4% raw) | -65.0% (-69.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.